Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.

Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP.

Circ Heart Fail. 2011 Mar;4(2):180-7. doi: 10.1161/CIRCHEARTFAILURE.110.958223. Epub 2010 Dec 22.

PMID:
21178018
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.

Ordu S, Ozhan H, Alemdar R, Aydin M, Caglar O, Yuksel H, Kandis H.

Tex Heart Inst J. 2012;39(1):30-5.

PMID:
22412224
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.

Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdés M, Januzzi JL.

Eur J Heart Fail. 2011 Jul;13(7):718-25. doi: 10.1093/eurjhf/hfr047. Epub 2011 May 6.

PMID:
21551163
[PubMed - indexed for MEDLINE]
4.

Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.

Lupón J, de Antonio M, Galán A, Vila J, Zamora E, Urrutia A, Bayes-Genis A.

Mayo Clin Proc. 2013 Mar;88(3):234-43. doi: 10.1016/j.mayocp.2012.09.016. Epub 2013 Feb 4. Erratum in: Mayo Clin Proc. 2013 May;88(5):532.

PMID:
23384388
[PubMed - indexed for MEDLINE]
5.

Multiple biomarkers for risk prediction in chronic heart failure.

Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AH, Goldberg LR, Jessup M, Cappola TP.

Circ Heart Fail. 2012 Mar 1;5(2):183-90. doi: 10.1161/CIRCHEARTFAILURE.111.965020. Epub 2012 Feb 23.

PMID:
22361079
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.

Adlbrecht C, Hülsmann M, Neuhold S, Strunk G, Pacher R.

J Heart Lung Transplant. 2013 May;32(5):533-8. doi: 10.1016/j.healun.2013.01.1048. Epub 2013 Feb 28.

PMID:
23453573
[PubMed - indexed for MEDLINE]
7.

Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.

de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.

Am Heart J. 2012 May;163(5):821-8. doi: 10.1016/j.ahj.2012.03.004.

PMID:
22607860
[PubMed - indexed for MEDLINE]
8.

Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.

Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS.

Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5.

PMID:
22869458
[PubMed - indexed for MEDLINE]
9.

Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

Bayes-Genis A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, Zamora E, Urrutia A, Lupón J.

J Am Coll Cardiol. 2014 Jan 21;63(2):158-66. doi: 10.1016/j.jacc.2013.07.087. Epub 2013 Sep 24.

PMID:
24076531
[PubMed - indexed for MEDLINE]
10.

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.

Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE, Lee RT.

Circulation. 2008 Apr 15;117(15):1936-44. doi: 10.1161/CIRCULATIONAHA.107.728022. Epub 2008 Mar 31.

PMID:
18378613
[PubMed - indexed for MEDLINE]
Free Article
11.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
[PubMed - indexed for MEDLINE]
12.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

PMID:
17996563
[PubMed - indexed for MEDLINE]
Free Article
13.

Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.

Yang JH, Choi JH, Ki YW, Kim DI, Kim DK, Park JR, Oh JK, Choi SH.

Korean J Intern Med. 2012 Sep;27(3):301-10. Epub 2012 Sep 1.

PMID:
23019395
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.

Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D.

Heart. 2007 Feb;93(2):226-31. Epub 2006 Aug 16.

PMID:
16914484
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

IVC diameter in patients with chronic heart failure: relationships and prognostic significance.

Pellicori P, Carubelli V, Zhang J, Castiello T, Sherwi N, Clark AL, Cleland JG.

JACC Cardiovasc Imaging. 2013 Jan;6(1):16-28. doi: 10.1016/j.jcmg.2012.08.012.

PMID:
23328557
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.

Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.

Atherosclerosis. 2013 Jun;228(2):478-84. doi: 10.1016/j.atherosclerosis.2013.03.017. Epub 2013 Mar 26.

PMID:
23582589
[PubMed - indexed for MEDLINE]
17.

Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.

Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P.

Int J Cardiol. 2008 Oct 13;129(3):373-8. Epub 2007 Dec 4.

PMID:
18054808
[PubMed - indexed for MEDLINE]
18.

Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure.

Bayes-Genis A, de Antonio M, Galán A, Sanz H, Urrutia A, Cabanes R, Cano L, González B, Díez C, Pascual T, Elosúa R, Lupón J.

Eur J Heart Fail. 2012 Jan;14(1):32-8. doi: 10.1093/eurjhf/hfr156.

PMID:
22179033
[PubMed - indexed for MEDLINE]
19.

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.

Rehman SU, Mueller T, Januzzi JL Jr.

J Am Coll Cardiol. 2008 Oct 28;52(18):1458-65. doi: 10.1016/j.jacc.2008.07.042.

PMID:
19017513
[PubMed - indexed for MEDLINE]
Free Article
20.

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

Franke J, Frankenstein L, Schellberg D, Bajrovic A, Wolter JS, Ehlermann P, Doesch AO, Nelles M, Katus HA, Zugck C.

Clin Res Cardiol. 2011 Dec;100(12):1059-67. doi: 10.1007/s00392-011-0340-1. Epub 2011 Jul 16.

PMID:
21779816
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk